Tackling Depression
5 Live Science Podcast
Dernanimab: A Turning Point in the Battle Against Alzheimer's Disease
Drug called Dernanimab has been hailed as a turning point in the fight against Alzheimer's disease. Scientists say that the drug which slowed the cognitive decline by 35% on average allowed people with Alzheimer's disease to keep their independence for longer. It targets the build-up in the brain of the chemical beta amyloid, which is thought to poison nerve cells and can cause Cognitive Decline.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
